Digitally‐delivered psychological therapies
|
Self‐management of symptoms of depression and anxiety |
Precision interventions; preventive treatments |
Lack of engagement; saturated consumer marketplace; claims outpacing clinical evidence |
Establishing evidence base for use in people with diagnosed mental disorders |
Smartphone data (active + passive)
|
Tracking mood and lifestyle in people with major depression, bipolar disorder and psychosis |
Machine learning towards individualized risk prediction and delivery of targeted “just in time” interventions |
Lack of validation across studies; establishing trust around data usage |
Data standards for interoperability and validation; industry‐academic partnerships around access |
Social media
|
Population level monitoring of mood and anxiety |
Real time monitoring of mental health state; accessible peer support |
Sampling bias; access to data from social media companies; privacy |
Industry‐academic partnerships and privacy standards |
Virtual reality
|
Exposure therapies |
Higher engagement and potentially higher efficacy than apps |
Increased accessibility |
Low‐cost headsets; expanded clinical targets |
Chatbots
|
|
Increased access to care |
Limited range of appropriate responses |
Establishing evidence base for use in people with diagnosed mental disorders |